Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Unilens Vision Inc.

Division of Bausch Health Companies Inc.
www.unilens.com

Latest From Unilens Vision Inc.

Medical Device Deals Update, August 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced June-July 2015.

Medical Device Deals

Deal Watch: Immunocore Raises Biggest EU Financing, $320M, For TCR Biologics Program

Celgene’s purchase of Receptos will add pipeline assets and help the biotech reach its end-of-decade revenue goals. Five Prime’s licensing deal with Inhibrx includes earn-outs for future “breakthrough therapy” designations.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Unilens Optical Corp.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Bausch Health Companies Inc.
  • Senior Management
  • Michael J Pecora, Chmn., Pres. & CEO
    Leonard F Barker, CFO
    Kelly McKnight-Goelz, VP, Sales & Mktg.
    Denis Rehse, Dir. R&D
  • Contact Info
  • Unilens Vision Inc.
    Phone: (727) 544-2531
    10431 72nd St. N
    Largo, FL 33777
    USA
UsernamePublicRestriction

Register